Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations.

por Bardot, V., Dutrillaux, A. M., Delattre, J. Y., Vega, F., Poisson, M., Dutrillaux, B., Luccioni, C.
Publicado 1994

Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice

por Leuraud, P, Taillandier, L, Aguirre-Cruz, L, Medioni, J, Crinière, E, Marie, Y, Dutrillaux, A M, Kujas, M, Duprez, A, Delattre, J-Y, Poupon, M-F, Sanson, M
Publicado 2003

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics

por Mazzocco, P, Barthélémy, C, Kaloshi, G, Lavielle, M, Ricard, D, Idbaih, A, Psimaras, D, Renard, M‐A, Alentorn, A, Honnorat, J, Delattre, J‐Y, Ducray, F, Ribba, B
Publicado 2015

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations

por Labussière, M, Di Stefano, A L, Gleize, V, Boisselier, B, Giry, M, Mangesius, S, Bruno, A, Paterra, R, Marie, Y, Rahimian, A, Finocchiaro, G, Houlston, R S, Hoang-Xuan, K, Idbaih, A, Delattre, J-Y, Mokhtari, K, Sanson, M
Publicado 2014

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222

por Enciso-Mora, V, Hosking, F J, Di Stefano, A L, Zelenika, D, Shete, S, Broderick, P, Idbaih, A, Delattre, J-Y, Hoang-Xuan, K, Marie, Y, Labussière, M, Alentorn, A, Ciccarino, P, Rossetto, M, Armstrong, G, Liu, Y, Gousias, K, Schramm, J, Lau, C, Hepworth, S J, Schoemaker, M, Strauch, K, Müller-Nurasyid, M, Schreiber, S, Franke, A, Moebus, S, Eisele, L, Swerdlow, A, Simon, M, Bondy, M, Lathrop, M, Sanson, M, Houlston, R S
Publicado 2013